Unknown

Dataset Information

0

Network-based machine learning approach to predict immunotherapy response in cancer patients.


ABSTRACT: Immune checkpoint inhibitors (ICIs) have substantially improved the survival of cancer patients over the past several years. However, only a minority of patients respond to ICI treatment (~30% in solid tumors), and current ICI-response-associated biomarkers often fail to predict the ICI treatment response. Here, we present a machine learning (ML) framework that leverages network-based analyses to identify ICI treatment biomarkers (NetBio) that can make robust predictions. We curate more than 700 ICI-treated patient samples with clinical outcomes and transcriptomic data, and observe that NetBio-based predictions accurately predict ICI treatment responses in three different cancer types-melanoma, gastric cancer, and bladder cancer. Moreover, the NetBio-based prediction is superior to predictions based on other conventional ICI treatment biomarkers, such as ICI targets or tumor microenvironment-associated markers. This work presents a network-based method to effectively select immunotherapy-response-associated biomarkers that can make robust ML-based predictions for precision oncology.

SUBMITTER: Kong J 

PROVIDER: S-EPMC9240063 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7785656 | biostudies-literature
| S-EPMC7327028 | biostudies-literature
2021-01-26 | GSE161019 | GEO
| S-EPMC6764170 | biostudies-literature
| S-EPMC7394436 | biostudies-literature
| S-EPMC7907939 | biostudies-literature
| S-EPMC8264776 | biostudies-literature
| S-EPMC4658146 | biostudies-literature
2021-01-26 | GSE161018 | GEO
2021-01-26 | GSE161010 | GEO